Results 11 to 20 of about 27,397 (239)

The Changing Epidemiology of Carbapenemase-Producing Enterobacterales [PDF]

open access: yesRambam Maimonides Medical Journal, 2022
Objective Israeli hospitals were confronted with a major national outbreak of carbapenemase-producing Enterobacterales (CPE) starting in 2006, caused predominantly by monoclonal Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae ...
Khetam Hussein   +7 more
doaj   +3 more sources

Fast genome-based delimitation of Enterobacterales species

open access: yesPLOS ONE, 2023
Average Nucleotide Identity (ANI) is becoming a standard measure for bacterial species delimitation. However, its calculation can take orders of magnitude longer than similarity estimates based on sampling of short nucleotides, compiled into so-called sketches. These estimates are widely used.
Julie E. Hernández-Salmerón   +2 more
openaire   +4 more sources

Virulence Factors and Antibiotic Resistance of Enterobacterales

open access: yesMicroorganisms, 2022
In the class Gammaproteobacteria, Enterobacterales are Gram-negative, facultatively anaerobic bacteria [...]
Dobroslava Bujňáková   +2 more
openaire   +3 more sources

Activity of mecillinam against carbapenem-resistant Enterobacterales

open access: yesJournal of Antimicrobial Chemotherapy, 2022
Abstract Background Despite the fact that carbapenem-resistant Enterobacterales (CRE) mostly cause urinary tract infections (UTIs), only few studies have focused on the efficacity of mecillinam against these CRE.
Emeraud, Cécile   +9 more
openaire   +3 more sources

Phylogenetic analysis reveals an ancient gene duplication as the origin of the MdtABC efflux pump. [PDF]

open access: yes, 2020
The efflux pumps from the Resistance-Nodulation-Division family, RND, are main contributors to intrinsic antibiotic resistance in Gram-negative bacteria. Among this family, the MdtABC pump is unusual by having two inner membrane components.
Górecki, Kamil, McEvoy, Megan M
core   +2 more sources

Differences in microbiota between two multilocus lineages of the sugarcane Aphid (Melanaphis sacchari) in the continental United States [PDF]

open access: yes, 2020
The sugarcane aphid (SCA), Melanaphis Sacchari (Zehntner) (Hemiptera: Aphididae), has been considered an invasive pest of sugarcane in the continental United States since 1977. Then, in 2013, SCA abruptly became a serious pest of U.S.
Antwi, Josephine B.   +11 more
core   +1 more source

Comparison of Three Phenotypic Methods of Carbapenemase Enzyme Detection to Identify Carbapenem-resistant Enterobacterales

open access: yesJournal of Pure and Applied Microbiology, 2022
The prevalence of multidrug-resistant gram-negative bacilli has increased worldwide. Critical care areas of most hospitals use carbapenem antibiotics for the empirical treatment of gram-negative bacterial (GNB) infections.
Amisha Piyush Khare   +3 more
doaj   +1 more source

Prevalence of Carbapenem-Resistant Enterobacterales, Acinetobacter baumannii, and Pseudomonas aeruginosa in a Tertiary Care Hospital in Eastern India: A Pilot Study

open access: yesJournal of Pure and Applied Microbiology, 2023
In recent years, a wide range of clinical infections are being caused by carbapenem-resistant Enterobacterales, Acinetobacter baumannii and Pseudomonas aeruginosa. This is a matter of great concern, as carbapenem-resistant infections have fewer treatment
Gaurav Verma   +6 more
doaj   +1 more source

Lung penetration, bronchopulmonary pharmacokinetic/pharmacodynamic profile and safety of 3 g of ceftolozane/tazobactam administered to ventilated, critically ill patients with pneumonia [PDF]

open access: yes, 2020
Objectives: Ceftolozane/tazobactam is approved for hospital-acquired/ventilator-associated bacterial pneumonia at double the dose (i.e. 2 g/1 g) recommended for other indications.
Adedoyin, Adedayo   +9 more
core   +1 more source

Activity of imipenem/relebactam against Enterobacterales and Pseudomonas aeruginosa in Spain. SMART 2016-2020 [PDF]

open access: yes, 2023
Objectives. To determine susceptibility to the novel β-lactam/β-lactamase inhibitor combination imipenem/relebactam in clinical isolates recovered from intra-abdominal (IAI), urinary (UTI), respiratory (RTI) and bloodstream (BSI) infections in the SMART (
Calvo, Jorge   +14 more
core   +1 more source

Home - About - Disclaimer - Privacy